Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of Hunter syndrome
3.2.1.2 Advancements in treatment options
3.2.1.3 Rising R&D expenditure
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Limited awareness and diagnosis
3.3 Growth potential analysis
3.4 Brand analysis
3.5 Future market trends
3.6 Pricing analysis
3.7 Regulatory landscape
3.8 Product pipeline analysis
3.9 Current therapies
3.10 Epidemiology scenario
3.11 Reimbursement scenario
3.12 Porter’s analysis
3.13 GAP analysis
3.14 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Enzyme replacement therapy (ERT)
5.3 Hematopoietic stem cell transplant (HSCT)
Chapter 6 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals
6.3 Clinics
6.4 Homecare settings
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Astellas Pharma Inc.
8.2 B.Braun
8.3 Baxter International
8.4 CHIESI Farmaceutici S.p.A.
8.5 Fresenius Kabi
8.6 GC Pharma
8.7 JCR Pharmaceuticals
8.8 Takeda Pharmaceutical Company Limited
8.9 Terumo Corporation
8.10 Thermo Fisher Scientific
